Who are glucose-based peritoneal dialysate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Huaren Peritoneal Dialysate, Physioneal 35, Physioneal 40, glucose peritoneal dialysis solution, Dianeal, Extraneal, Nutrineal, Experimental Peritoneal Dialysis Solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/glucose-based-peritoneal-dialysate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

glucose-based peritoneal dialysate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

glucose-based peritoneal dialysate (glucose-based peritoneal dialysate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Peritoneal dialysis solution. Area: Nephrology.

marketed Peritoneal dialysis solution Nephrology Small molecule Live · refreshed every 30 min

Target snapshot

glucose-based peritoneal dialysate (glucose-based peritoneal dialysate) — Chinese University of Hong Kong. Glucose-based peritoneal dialysate facilitates removal of uremic waste products and excess fluid from the blood across the peritoneal membrane during peritoneal dialysis.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
glucose-based peritoneal dialysate TARGET	glucose-based peritoneal dialysate	Chinese University of Hong Kong	marketed	Peritoneal dialysis solution
Huaren Peritoneal Dialysate	Huaren Peritoneal Dialysate	Chinese PLA General Hospital	marketed	Peritoneal dialysis solution
Physioneal 35	Physioneal 35	University of Erlangen-Nürnberg Medical School	marketed	Peritoneal dialysis solution
Physioneal 40	Physioneal 40	University of Erlangen-Nürnberg Medical School	marketed	Peritoneal dialysis solution
glucose peritoneal dialysis solution	glucose peritoneal dialysis solution	Chengdu Qingshan Likang Pharmaceutical Co., Ltd	marketed	Peritoneal dialysis solution
Dianeal, Extraneal, Nutrineal	Dianeal, Extraneal, Nutrineal	Vantive Health LLC	phase 3	Peritoneal dialysis solution
Experimental Peritoneal Dialysis Solution	Experimental Peritoneal Dialysis Solution	Vantive Health LLC	phase 3	Peritoneal dialysis solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Peritoneal dialysis solution class)

University of Erlangen-Nürnberg Medical School · 2 drugs in this class
Vantive Health LLC · 2 drugs in this class
Chengdu Qingshan Likang Pharmaceutical Co., Ltd · 1 drug in this class
Chinese PLA General Hospital · 1 drug in this class
Chinese University of Hong Kong · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). glucose-based peritoneal dialysate — Competitive Intelligence Brief. https://druglandscape.com/ci/glucose-based-peritoneal-dialysate. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing